Perez EA - Search Results

1

Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors.

Mincey BA, Duh MS, Thomas SK, Moyneur E, Marynchencko M, Boyce SP, Mallett D, Perez EA. Mincey BA, et al. Among authors: perez ea. Clin Breast Cancer. 2006 Jun;7(2):127-32. doi: 10.3816/CBC.2006.n.021. Clin Breast Cancer. 2006. PMID: 16800971

2

Adjuvant therapy trials of radiotherapy and systemic treatment for breast cancer.

Mincey BA, Vallow LA, Perez EA. Mincey BA, et al. Among authors: perez ea. Curr Oncol Rep. 2002 Jan;4(1):1. doi: 10.1007/s11912-002-0040-0. Curr Oncol Rep. 2002. PMID: 11734107 No abstract available.

3

Adjuvant therapy for breast cancer: recommendations for management based on consensus review and recent clinical trials.

Mincey BA, Palmieri FM, Perez EA. Mincey BA, et al. Among authors: perez ea. Oncologist. 2002;7(3):246-50. doi: 10.1634/theoncologist.7-3-246. Oncologist. 2002. PMID: 12065798 Free article. Review.

4

Recent advances in adjuvant therapy for breast cancer.

Palmieri FM, Perez EA. Palmieri FM, et al. Among authors: perez ea. Semin Oncol Nurs. 2003 Nov;19(4 Suppl 2):10-6. doi: 10.1053/j.soncn.2003.09.004. Semin Oncol Nurs. 2003. PMID: 14702916 Review.

5

Gemcitabine and platinum combinations in patients with breast cancer previously treated with anthracyclines and/or taxanes.

Perez EA. Perez EA. Clin Breast Cancer. 2004 Jan;4 Suppl 3:S113-6. doi: 10.3816/cbc.2004.s.004. Clin Breast Cancer. 2004. PMID: 14754468 Review.

6

Advances in screening, diagnosis, and treatment of breast cancer.

Mincey BA, Perez EA. Mincey BA, et al. Among authors: perez ea. Mayo Clin Proc. 2004 Jun;79(6):810-6. doi: 10.4065/79.6.810. Mayo Clin Proc. 2004. PMID: 15182098 Review.

7

Management recommendations for adjuvant systemic breast cancer therapy.

Perez EA. Perez EA. Breast Dis. 2004;21:15-21. doi: 10.3233/bd-2004-21103. Breast Dis. 2004. PMID: 15687718 Review. No abstract available.

8

Serum soluble epidermal growth factor receptor concentrations decrease in postmenopausal metastatic breast cancer patients treated with letrozole.

Lafky JM, Baron AT, Cora EM, Hillman DW, Suman VJ, Perez EA, Ingle JN, Maihle NJ. Lafky JM, et al. Among authors: perez ea. Cancer Res. 2005 Apr 15;65(8):3059-62. doi: 10.1158/0008-5472.CAN-05-0067. Cancer Res. 2005. PMID: 15833834

9

Molecularly targeted therapies for breast cancer.

Hobday TJ, Perez EA. Hobday TJ, et al. Among authors: perez ea. Cancer Control. 2005 Apr;12(2):73-81. doi: 10.1177/107327480501200202. Cancer Control. 2005. PMID: 15855890 Free article. Review.

10

North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer.

Moreno-Aspitia A, Perez EA. Moreno-Aspitia A, et al. Among authors: perez ea. Clin Breast Cancer. 2005 Oct;6(4):361-4. doi: 10.3816/CBC.2005.n.042. Clin Breast Cancer. 2005. PMID: 16277889 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

627 results

Search Page

Filters